Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line.

Neurochem Int 2004 Jun;44(7):487-96

Neurotec Department, Division of Experimental Geriatrics, Karolinska Institutet, KASPAC, Novum pl 5, S-141 86 Huddinge, Sweden.

Human neuroblastoma SH-SY5Y cells stably transfected with both wild-type and exon-9 deleted (deltaE9) presenilin constructs were used to study the role of the presenilin proteins during differentiation. Cells transfected with either wild-type or deltaE9 PS1, of which the latter abolishes normal endoproteolytic cleavage of the protein, showed no obvious differences in their ability to differentiate to a neuronal-like phenotype upon treatment with retinoic acid (RA). A defined pattern of PS1 expression was observed during differentiation with both RA and the phorbol ester TPA. Full-length PS1 was shown to increase dramatically within 5-24 h of RA treatment. TPA gave an earlier and longer lasting increase in full-length PS1 levels. The intracellular distribution pattern of PS1 was markedly altered following RA treatment. Within 24h PS1 was highly up-regulated throughout the cell body around the nucleus. Between 2 and 4 weeks PS1 staining appeared punctate and also localised to the nucleus. Increases in PS1 expression upon treatment with RA and TPA were blocked by treatment with cycloheximide, indicating a role of de-novo protein synthesis in this effect. PS2 expression remained unchanged during differentiation. Levels of full-length PS1 were also seen to increase during neurogenesis and neuronal differentiation in the forebrain of first trimester human foetuses between 6.5 and 11 weeks. These combined observations support the idea that PS1 is involved in neuronal differentiation by a mechanism likely independent of endoproteolysis of the protein.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuint.2003.09.002DOI Listing
June 2004

Publication Analysis

Top Keywords

full-length ps1
12
ps1
10
transfected wild-type
8
neuroblastoma sh-sy5y
8
neuronal differentiation
8
treatment tpa
8
ps1 increase
8
human neuroblastoma
8
ps1 expression
8
pattern ps1
8
differentiation
6
treatment
5
highly up-regulated
4
altered treatment
4
treatment 24h
4
up-regulated cell
4
ps1 highly
4
24h ps1
4
nucleus weeks
4
staining appeared
4

Similar Publications

Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.

Neuroscience 2000 ;95(2):593-601

Karolinska Institutet, Department of Geriatric Medicine, Huddinge, Sweden.

Mutations in the presenilin-1 (PS1) and presenilin-2 (PS2) genes account for the majority of early-onset familial Alzheimer's disease cases. Recent studies suggest that presenilin gene mutations predispose cells to apoptosis by mechanisms involving altered calcium homeostasis and oxidative damage. In the present study, we determined whether PS1 mutations also sensitize cells to hyperosmotic stress-induced apoptosis. Read More

View Article and Full-Text PDF
February 2000

Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells.

Exp Cell Res 2000 Mar;255(2):192-206

Department of Pathology, University of Melbourne, Parkville, Victoria, 3052, Australia.

Mutations in the presenilin 1 and 2 (PS1 and PS2) genes cause most cases of early onset Alzheimer's disease. The genes encode two homologous multipass membrane proteins. Since the endogenous expression of PS2 has been poorly analyzed to date, we studied PS2 expression and localization in cultured human neuroblastoma cells and mouse neuronal cells. Read More

View Article and Full-Text PDF
March 2000

Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells.

J Neurosci Res 2001 Oct;66(1):122-34

Karolinska Institute, NEUROTEC, Division of Geriatric Medicine, KFC, NOVUM, Huddinge, Sweden.

Presenilins (PSs) are mutated in a majority of familial Alzheimer disease (FAD) cases. Mutated PSs may cause FAD by a number of pro-apoptotic mechanisms, or by regulating gamma-secretase activity, a protease involved in beta-amyloid precursor protein processing to the neurotoxic beta-amyloid peptide. Besides their normal endoproteolytic processing, PSs are substrates for caspases, being cleaved to alternative N-terminal and C-terminal fragments. Read More

View Article and Full-Text PDF
October 2001

The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations.

J Biol Chem 2002 Sep 16;277(39):36646-55. Epub 2002 Jul 16.

Section of Experimental Geriatrics, Karolinska Institutet, Neurotec, Kliniskt Forskningscentrum (KFC), 141 86 Huddinge, Sweden.

We studied effects of the familial Alzheimer's disease presenilin 1 (PS1) exon 9 deletion (PS1-DeltaE9) mutation on basal and carbachol-stimulated phosphoinositide (PI) hydrolysis and intracellular Ca(2+) concentrations ([Ca(2+)](i)) in human SH-SY5Y neuroblastoma cells. We demonstrate that PS1-DeltaE9 cells have an enhanced basal PI hydrolysis and [Ca(2+)](i) as compared with both wild type PS1 (PS1-WT) and nontransfected (NT) cells. Both were reversed by the phospholipase C (PLC) inhibitor neomycin. Read More

View Article and Full-Text PDF
September 2002